Litcius/Paper detail

Icariside II: Anticancer Potential and Molecular Targets in Solid Cancers

Fei Xu, Qiaolan Wu, Lei Li, Jie Gong, Ran Huo, Wenqiang Cui

2021Frontiers in Pharmacology48 citationsDOIOpen Access PDF

Abstract

. It possesses multiple biological and pharmacological properties, including anti-inflammatory, anticancer, and anti-osteoporotic properties. In recent years, apoptosis has become the hot spot in anticancer therapies. Icariside II exerts positive effects on inducing apoptosis and inhibiting proliferation in various cancers. The antitumorigenic activity of Icariside II was also proven through cell cycle arrest, triggering autophagy, reducing cellular metabolism, and inhibiting cancer metastasis and tumor-associated angiogenesis. Additionally, Icariside II, as a natural product, contributed to a synergistic effect alongside chemotherapeutic drugs. Due to its poor aqueous solubility and permeability, more strategies were developed to improve its therapeutic effects. This review aimed to summarize the chemopreventive properties of Icariside II in solid tumors and reveal its underlying molecular mechanisms.

Topics & Concepts

PharmacologyApoptosisAngiogenesisCell cycle checkpointMedicineMetastasisCancer researchCancerChemistryCell cycleTraditional medicineBiochemistryInternal medicineMedicinal Plant Pharmacodynamics ResearchCancer-related molecular mechanisms researchNatural product bioactivities and synthesis
Icariside II: Anticancer Potential and Molecular Targets in Solid Cancers | Litcius